Soru

Zorluk: ZorGeneral Internal Medicine

A general internist is conducting preoperative evaluations for several patients scheduled for elective surgeries next week. Match each patient's chronic medication scenario to the most appropriate perioperative management recommendation.

  • Lisinopril for essential hypertension in a patient undergoing an elective laparoscopic cholecystectomy.Withhold on the morning of surgery to minimize the risk of refractory intraoperative hypotension.
  • Warfarin for atrial fibrillation (CHA2DS2-VASc score = 1) in a patient scheduled for an elective total hip arthroplasty.Discontinue 5 days prior to surgery without initiating bridging anticoagulation therapy.
  • Empagliflozin for type 2 diabetes mellitus in a patient undergoing an elective open bowel resection.Discontinue 3 to 4 days prior to surgery to reduce the risk of perioperative euglycemic ketoacidosis.
  • Sublingual buprenorphine-naloxone for opioid use disorder in a patient scheduled for an elective lumbar spinal fusion.Continue the current maintenance dose throughout the perioperative period and utilize multimodal analgesia.
  • Raloxifene for osteoporosis in a patient undergoing an elective total knee arthroplasty.Discontinue 4 weeks prior to surgery due to the significantly elevated risk of postoperative venous thromboembolism.

Cevap

Lisinopril is withheld the morning of surgery; Warfarin is stopped 5 days prior without bridging; Empagliflozin is stopped 3-4 days prior; Buprenorphine is continued throughout; and Raloxifene is stopped 4 weeks prior.
Correct matching requires identifying the specific physiological risks posed by each medication during surgery and anesthesia. ACE inhibitors risk severe vasoplegia; SGLT2 inhibitors risk euglycemic DKA; SERMs risk VTE. Conversely, stopping buprenorphine risks severe withdrawal, and low-risk warfarin patients do not require bridging.

Adım Adım Çözüm

1
Analyze the ACE inhibitor scenario.
Lisinopril matches with withholding on the morning of surgery.
Prevents refractory hypotension during anesthesia induction.
2
Analyze the Warfarin scenario.
Warfarin matches with stopping 5 days prior without bridging.
Low thromboembolic risk (CHA2DS2-VASc = 1) does not warrant bridging, but INR must normalize.
3
Analyze the SGLT2 inhibitor scenario.
Empagliflozin matches with stopping 3-4 days prior.
Mitigates the risk of perioperative euglycemic diabetic ketoacidosis.
4
Analyze the Buprenorphine scenario.
Buprenorphine matches with continuing the current maintenance dose.
Prevents opioid withdrawal and maintains baseline tolerance for multimodal pain management.
5
Analyze the SERM scenario.
Raloxifene matches with stopping 4 weeks prior.
Reduces the elevated risk of venous thromboembolism associated with major orthopedic surgery.

Anahtar Kavram

Perioperative medication management requires balancing the risks of disease exacerbation upon discontinuation against the physiological stresses and drug interactions associated with anesthesia and surgery.
Bu soruyu puanla